High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma
{{output}}
Despite the generally favorable prognosis of differentiated thyroid carcinoma (DTC) following surgery and radioactive iodine (RAI) therapy, approximately 10% of cases eventually develop resistance to RAI. This condition, known as radioiodine-refractory differe... ...
